Photo from wikipedia
The development of cystic fibrosis-related diabetes (CFRD) often leads to poorer outcomes in patients with cystic fibrosis including increases in pulmonary exacerbations, poorer lung function and early mortality. This review… Click to show full abstract
The development of cystic fibrosis-related diabetes (CFRD) often leads to poorer outcomes in patients with cystic fibrosis including increases in pulmonary exacerbations, poorer lung function and early mortality. This review highlights the many factors contributing to the clinical decline seen in patients diagnosed with CFRD, highlighting the important role of nutrition, the direct effect of hyperglycaemia on the lungs, the immunomodulatory effects of high glucose levels and the potential role of genetic modifiers in CFRD. Cystic fibrosis (CF)-related diabetes remains one of the most important comorbidities for patients with CF because of the impact on lung function and mortality. There are numerous factors in addition to infection that contribute to the negative effects of CF-related diabetes. https://bit.ly/3nSPFW6
Journal Title: European Respiratory Review
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!